EA
IART icon

Emerald Acquisition’s Integra LifeSciences IART Stock Holding History

Emerald Acquisition’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$16.2M Sell
392,294
-130,822
-25% -$5.48M 0.03% 628
2016
Q2 		$20.9M Buy
+523,116
New +$18.8M 0.04% 576

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Acquisition's IART Position: Q3 2016 in Review

Emerald Acquisition reduced its Integra LifeSciences (IART) stake by 25% in Q3 2016, selling an estimated $5.48M and leaving 392,294 shares worth $16.2M. The position accounts for 0.03% of the portfolio, ranked #628.

Emerald Acquisition first reported a position in IART in Q2 2016 and has held it in 2 quarters since. The position peaked at $20.9M in Q2 2016. 234 funds tracked by Wall St. Rank hold IART as of Q3 2016.

  • Emerald Acquisition held 392,294 shares of Integra LifeSciences worth $16.2M as of Q3 2016.
  • Emerald Acquisition sold 130,822 Integra LifeSciences shares in Q3 2016, an estimated $5.48M.
  • Integra LifeSciences made up 0.03% of Emerald Acquisition's portfolio in Q3 2016, its #628 holding.
  • Emerald Acquisition first reported a position in Integra LifeSciences in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Integra LifeSciences position peaked at $20.9M in Q2 2016.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.